Please Wait.....
Report
Global Nanomedicine Market, By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes), By Nanoparticle Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others), By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others) By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others), By Region and Competition Forecast & Opportunities, 2027
Market Report I 2022-06-01 I 111 Pages I TechSci Research
The global nanomedicine market is expected to grow at an impressive CAGR of 8.28% in the forecast period, 2023-2027, to reach USD242655.19 million by 2027. The market is driven by the factors such as the growing healthcare expenditure and increased demand for personalized medicines. The massive prevalence of chronic and lifestyle disorders such as cancer and cardiovascular diseases across the globe is accelerating the application of nanomedicine in various healthcare applications. Also, the high-end investments in research and development activities by public and private players to find novel solutions for drug delivery and increase the effectiveness of drugs are expected to create lucrative growth opportunities for the global nanomedicine market in the forecast period.
Nanomedicines are considered very effective in treating chronic diseases such as cancer, dementia, and diabetes as they fuel the metabolism of medications in the body. They deliver the drugs at the target site in the right proportion. The market's availability of nanomedical products such as DNA probes, nanosensors, and nanoparticle-based imaging agents is increasing the demand. However, the high cost associated with the nanomedicine manufacturing process and research and development activities may hinder the global nanomedicine market in the forecast period.
The global nanomedicine market is divided into nano molecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape. Based on application, the nanomedicine market is divided into drug delivery, vaccines, diagnostic imaging, regenerative medicine, and others. Drug delivery applications dominated the market in 2021 and captured 30.23% of the overall market share. This segment is expected to maintain its dominance over the next five years. The rise in awareness about the benefits of nanomedicine in drug delivery applications and the increased prevalence of diseases drives the demand for nanomedicines for drug delivery applications.
The major market players operating in the global nanomedicine market are Pfizer Inc., Janssen Pharmaceuticals, Sanofi S.A., Amgen Inc., Moderna, Inc., Novo Nordisk A/S, Genentech, Inc., Celgene Corporation, Vifor Pharma Group, Teva Pharmaceutical Industries Ltd., among others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027
Objective of the Study:
- To analyze the historical growth and the market size of the global nanomedicine market from 2017 to 2021.
- To estimate and forecast the market size of the global nanomedicine market from 2023 to 2027 and growth rate until 2027.
- To classify and forecast the global nanomedicine market is divided into nanomolecule type, nanoparticles type, application, disease indication, regional distribution, and competitive landscape.
- To identify drivers and challenges for the global nanomedicine market.
- To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global nanomedicine market.
- To conduct pricing analysis for the global nanomedicine market.
- To identify and analyze the profile of leading players operating in global nanomedicine market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading nanomedicine manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the nanomedicine manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the nanomedicine manufacturers, distribution channels and presence of all major players operating in the global nanomedicine market all over the world.
TechSci Research calculated the global nanomedicine market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Nanomedicine manufacturers/ suppliers/ distributors
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to nanomedicine
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as nanomedicine manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.
Report Scope:
In this report, global nanomedicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Nanomedicine Market, By Nanomolecule Type:
o Nanoparticles
o Nanoshells
o Nanodevices
o Nanotubes
- Nanomedicine Market, By Nanoparticles Type:
o Polymer-based
o Lipid-based
o Nanocrystals
o Inorganic
o Others
- Nanomedicine Market, By Application:
o Drug Delivery
o Vaccines
o Diagnostic Imaging
o Regenerative Medicine
o Others
- Nanomedicine Market, By Disease Indication:
o Oncological Diseases
o Infectious Diseases
o Orthopedic Disorders
o Cardiovascular Diseases
o Others
- Nanomedicine Market, By Region:
o North America
- United States
- Canada
- Mexico
o Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Denmark
o Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Malaysia
- Vietnam
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- Turkey
- Israel
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global nanomedicine market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Nanomedicine Market
5. Voice of Customer
5.1. Factors Increasing the demand for Nanomedicine
5.2. Preference, By Nanomolecule Type
5.3. Demand for Nanomedicine, By Indication
5.4. Brand Awareness
6. Global Nanomedicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
6.2.1.1. By Nanoparticle Type (Polymer - based, Lipid - based, Nanocrystals, Inorganic, Others)
6.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
6.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America Nanomedicine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
7.2.1.1. By Nanoparticle Type (Polymer - based, Lipid - based, Nanocrystals, Inorganic, Others)
7.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
7.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Nanomedicine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Nanomolecule Type
7.3.1.2.1.1. By Nanoparticle Type
7.3.1.2.2. By Application
7.3.1.2.3. By Disease Indication
7.3.2. Canada Nanomedicine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Nanomolecule Type
7.3.2.2.1.1. By Nanoparticle Type
7.3.2.2.2. By Application
7.3.2.2.3. By Disease Indication
7.3.3. Mexico Nanomedicine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Nanomolecule Type
7.3.3.2.1.1. By Nanoparticle Type
7.3.3.2.2. By Application
7.3.3.2.3. By Disease Indication
8. Europe Nanomedicine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
8.2.1.1. By Nanoparticle Type (Polymer - based, Lipid - based, Nanocrystals, Inorganic, Others)
8.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
8.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Nanomedicine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Nanomolecule Type
8.3.1.2.1.1. By Nanoparticle Type
8.3.1.2.2. By Application
8.3.1.2.3. By Disease Indication
8.3.2. France Nanomedicine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Nanomolecule Type
8.3.2.2.1.1. By Nanoparticle Type
8.3.2.2.2. By Application
8.3.2.2.3. By Disease Indication
8.3.3. United Kingdom Nanomedicine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Nanomolecule Type
8.3.3.2.1.1. By Nanoparticle Type
8.3.3.2.2. By Application
8.3.3.2.3. By Disease Indication
8.3.4. Italy Nanomedicine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Nanomolecule Type
8.3.4.2.1.1. By Nanoparticle Type
8.3.4.2.2. By Application
8.3.4.2.3. By Disease Indication
8.3.5. Spain Nanomedicine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Nanomolecule Type
8.3.5.2.1.1. By Nanoparticle Type
8.3.5.2.2. By Application
8.3.5.2.3. By Disease Indication
8.3.6. Denmark Nanomedicine Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Nanomolecule Type
8.3.6.2.1.1. By Nanoparticle Type
8.3.6.2.2. By Application
8.3.6.2.3. By Disease Indication
9. Asia Pacific Nanomedicine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
9.2.1.1. By Nanoparticle Type (Polymer - based, Lipid - based, Nanocrystals, Inorganic, Others)
9.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
9.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
9.2.4. By Country
9.3. Asia Pacific: Country Analysis
9.3.1. China Nanomedicine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Nanomolecule Type
9.3.1.2.1.1. By Nanoparticle Type
9.3.1.2.2. By Application
9.3.1.2.3. By Disease Indication
9.3.2. Japan Nanomedicine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Nanomolecule Type
9.3.2.2.1.1. By Nanoparticle Type
9.3.2.2.2. By Application
9.3.2.2.3. By Disease Indication
9.3.3. India Nanomedicine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Nanomolecule Type
9.3.3.2.1.1. By Nanoparticle Type
9.3.3.2.2. By Application
9.3.3.2.3. By Disease Indication
9.3.4. Australia Nanomedicine Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Nanomolecule Type
9.3.4.2.1.1. By Nanoparticle Type
9.3.4.2.2. By Application
9.3.4.2.3. By Disease Indication
9.3.5. South Korea Nanomedicine Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Nanomolecule Type
9.3.5.2.1.1. By Nanoparticle Type
9.3.5.2.2. By Application
9.3.5.2.3. By Disease Indication
9.3.6. Malaysia Nanomedicine Market Outlook
9.3.6.1. Market Size & Forecast
9.3.6.1.1. By Value
9.3.6.2. Market Share & Forecast
9.3.6.2.1. By Nanomolecule Type
9.3.6.2.1.1. By Nanoparticle Type
9.3.6.2.2. By Application
9.3.6.2.3. By Disease Indication
9.3.7. Vietnam Nanomedicine Market Outlook
9.3.7.1. Market Size & Forecast
9.3.7.1.1. By Value
9.3.7.2. Market Share & Forecast
9.3.7.2.1. By Nanomolecule Type
9.3.7.2.1.1. By Nanoparticle Type
9.3.7.2.2. By Application
9.3.7.2.3. By Disease Indication
10. South America Nanomedicine Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
10.2.1.1. By Nanoparticle Type (Polymer - based, Lipid - based, Nanocrystals, Inorganic, Others)
10.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
10.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nanomedicine Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Nanomolecule Type
10.3.1.2.1.1. By Nanoparticle Type
10.3.1.2.2. By Application
10.3.1.2.3. By Disease Indication
10.3.2. Argentina Nanomedicine Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Nanomolecule Type
10.3.2.2.1.1. By Nanoparticle Type
10.3.2.2.2. By Application
10.3.2.2.3. By Disease Indication
10.3.3. Colombia Nanomedicine Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Nanomolecule Type
10.3.3.2.1.1. By Nanoparticle Type
10.3.3.2.2. By Application
10.3.3.2.3. By Disease Indication
11. Middle East and Africa Nanomedicine Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
11.2.1.1. By Nanoparticle Type (Polymer - based, Lipid - based, Nanocrystals, Inorganic, Others)
11.2.2. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
11.2.3. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
11.2.4. By Country
11.3. Middle East and Africa: Country Analysis
11.3.1. Turkey Nanomedicine Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Nanomolecule Type
11.3.1.2.1.1. By Nanoparticle Type
11.3.1.2.2. By Application
11.3.1.2.3. By Disease Indication
11.3.2. Israel Nanomedicine Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Nanomolecule Type
11.3.2.2.1.1. By Nanoparticle Type
11.3.2.2.2. By Application
11.3.2.2.3. By Disease Indication
11.3.3. South Africa Nanomedicine Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Nanomolecule Type
11.3.3.2.1.1. By Nanoparticle Type
11.3.3.2.2. By Application
11.3.3.2.3. By Disease Indication
11.3.4. Saudi Arabia Nanomedicine Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Nanomolecule Type
11.3.4.2.1.1. By Nanoparticle Type
11.3.4.2.2. By Application
11.3.4.2.3. By Disease Indication
11.3.5. UAE Nanomedicine Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Nanomolecule Type
11.3.5.2.1.1. By Nanoparticle Type
11.3.5.2.2. By Application
11.3.5.2.3. By Disease Indication
11.3.6. Kuwait Nanomedicine Market Outlook
11.3.6.1. Market Size & Forecast
11.3.6.1.1. By Value
11.3.6.2. Market Share & Forecast
11.3.6.2.1. By Nanomolecule Type
11.3.6.2.1.1. By Nanoparticle Type
11.3.6.2.2. By Application
11.3.6.2.3. By Disease Indication
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends and Developments
14. Competitive Landscape
14.1. Pfizer Inc.
14.2. Janssen Pharmaceuticals
14.3. Sanofi S.A.
14.4. Amgen Inc.
14.5. Moderna, Inc.
14.6. Novo Nordisk A/S
14.7. Genentech, Inc
14.8. Celgene Corporation
14.9. Vifor Pharma Ltd.
14.10. Teva Pharmaceutical Industries Ltd.
15. Strategic Recommendations
Figure 1: Global Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 3: Global Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 4: Global Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 5: Global Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 6: Global Nanomedicine Market Share, By Region, By Value, 2017-2027F
Figure 7: Global Nanomedicine Market Share, By Company, By Value, 2021
Figure 8: Global Nanomedicine Market Map, By Nanomolecule Type, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: North America Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 10: North America Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 11: North America Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 12: North America Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 13: North America Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 14: North America Nanomedicine Market Share, By Country, By Value, 2017-2027F
Figure 15: United States Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 16: United States Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 17: United States Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 18: United States Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 19: United States Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 20: Canada Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 21: Canada Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 22: Canada Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 23: Canada Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 24: Canada Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 25: Mexico Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 26: Mexico Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 27: Mexico Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 28: Mexico Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 29: Mexico Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 30: Europe Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 31: Europe Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 32: Europe Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 33: Europe Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 34: Europe Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 35: Europe Nanomedicine Market Share, By Country, By Value, 2017-2027F
Figure 36: Germany Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 37: Germany Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 38: Germany Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 39: Germany Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 40: Germany Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 41: France Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 42: France Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 43: France Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 44: France Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 45: France Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 46: United Kingdom Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 47: United Kingdom Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 48: United Kingdom Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 49: United Kingdom Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 50: United Kingdom Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 51: Italy Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 52: Italy Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 53: Italy Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 54: Italy Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 55: Italy Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 56: Spain Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 57: Spain Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 58: Spain Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 59: Spain Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 60: Spain Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 61: Denmark Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 62: Denmark Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 63: Denmark Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 64: Denmark Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 65: Denmark Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 66: Middle East & Africa Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 67: Middle East & Africa Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 68: Middle East & Africa Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 69: Middle East & Africa Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 70: Middle East & Africa Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 71: Middle East & Africa Nanomedicine Market Share, By Country, By Value, 2017-2027F
Figure 72: China Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 73: China Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 74: China Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 75: China Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 76: China Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 77: Japan Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 78: Japan Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 79: Japan Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 80: Japan Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 81: Japan Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 82: India Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 83: India Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 84: India Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 85: India Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 86: India Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 87: Australia Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 88: Australia Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 89: Australia Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 90: Australia Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 91: Australia Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 92: South Korea Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 93: South Korea Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 94: South Korea Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 95: South Korea Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 96: South Korea Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 97: Malaysia Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 98: Malaysia Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 99: Malaysia Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 100: Malaysia Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 101: Malaysia Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 102: Vietnam Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 103: Vietnam Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 104: Vietnam Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 105: Vietnam Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 106: Vietnam Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 107: South America Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 108: South America Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 109: South America Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 110: South America Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 111: South America Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 112: South America Nanomedicine Market Share, By Country, By Value, 2017-2027F
Figure 113: Brazil Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 114: Brazil Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 115: Brazil Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 116: Brazil Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 117: Brazil Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 118: Argentina Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 119: Argentina Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 120: Argentina Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 121: Argentina Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 122: Argentina Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 123: Colombia Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 124: Colombia Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 125: Colombia Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 126: Colombia Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 127: Colombia Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 128: Middle East & Africa Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 129: Middle East & Africa Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 130: Middle East & Africa Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 131: Middle East & Africa Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 132: Middle East & Africa Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 133: Middle East & Africa Nanomedicine Market Share, By Country, By Value, 2017-2027F
Figure 134: Turkey Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 135: Turkey Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 136: Turkey Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 137: Turkey Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 138: Turkey Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 139: Israel Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 140: Israel Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 141: Israel Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 142: Israel Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 143: Israel Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 144: South Africa Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 145: South Africa Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 146: South Africa Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 147: South Africa Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 148: South Africa Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 149: Saudi Arabia Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 150: Saudi Arabia Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 151: Saudi Arabia Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 152: Saudi Arabia Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 153: Saudi Arabia Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 154: UAE Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 155: UAE Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 156: UAE Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 157: UAE Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 158: UAE Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
Figure 159: Kuwait Nanomedicine Market Size, By Value (USD Million), 2017-2027F
Figure 160: Kuwait Nanomedicine Market Share, By Nanomolecule Type, By Value, 2017-2027F
Figure 161: Kuwait Nanomedicine Market Share, By Nanoparticle Type, By Value, 2017-2027F
Figure 162: Kuwait Nanomedicine Market Share, By Application, By Value, 2017-2027F
Figure 163: Kuwait Nanomedicine Market Share, By Disease Indication, By Value, 2017-2027F
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security